| A different approach to resistant hypertension. | |
| | |
MedLine Citation:
|
PMID: 17569203 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Prescription audits document that patients with resistant hypertension are often treated with several vasodilators, with less emphasis on diuretics and beta-blockers. Patients who do not respond to several vasodilators appear to be vasodilator-insensitive; they may be a selected-out cohort who require diuresis or catecholamine suppression for further blood pressure control. |
| | |
Authors:
|
Sheldon Hirsch |
Related Documents
:
|
7252843 - Antihypertensive and hemodynamic actions of sch 19927, the r,r-isomer and labetalol. 16822893 - Nebivolol: a third-generation beta-adrenergic blocker. 300133 - Control of myocardial performance early after open-heart operations by vasodilator trea... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cleveland Clinic journal of medicine Volume: 74 ISSN: 0891-1150 ISO Abbreviation: Cleve Clin J Med Publication Date: 2007 Jun |
Date Detail:
|
Created Date: 2007-06-15 Completed Date: 2007-09-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703441 Medline TA: Cleve Clin J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 449-56 Citation Subset: IM |
Affiliation:
|
Michael Reese Hospital, Chicago, IL, USA. Shelman100@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Diuretics / therapeutic use* Drug Monitoring Humans Hypertension / drug therapy* Physical Examination Treatment Failure* Vasodilator Agents / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Diuretics; 0/Vasodilator Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lung cancer screening: is it time for a change in policy?
Next Document: Curcumin: the Indian solid gold.